PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity
about
Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UsePolymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.Genes implicated in thiopurine-induced toxicity: Comparing TPMT enzyme activity with clinical phenotype and exome data in a paediatric IBD cohort.The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes.Association of ITPA genotype with event-free survival and relapse rates in children with acute lymphoblastic leukemia undergoing maintenance therapyPACSIN2 polymorphism is associated with thiopurine-induced hematological toxicity in children with acute lymphoblastic leukaemia undergoing maintenance therapy.TPMT genetic variants are associated with increased rejection with azathioprine use in heart transplantation.Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia.Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.Pharmacogenetics of childhood acute lymphoblastic leukemia.Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.Update on thiopurine pharmacogenetics in inflammatory bowel disease.Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia.Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine.Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol.NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.Tip-to-tip interaction in the crystal packing of PACSIN 2 is important in regulating tubulation activity.From pharmacogenetics to pharmacometabolomics: SAM modulates TPMT activity.Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait.Differential effects of thiopurine methyltransferase (TPMT) and multidrug resistance-associated protein gene 4 (MRP4) on mercaptopurine toxicity.Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring
P2860
Q28068930-2EED5433-2AD3-41F5-9A38-9BDA726FCEFEQ30244222-C5F8A937-08FC-451C-A285-5C6C256CF175Q31134780-B6B232BF-5352-4D6D-8C68-B53B43E73716Q33632120-70F835BB-A1E9-4C65-938F-1FFABF4EC706Q33637143-69F56B01-724B-436F-8062-0E32960EA657Q34323258-CAC03DEF-FF71-4C77-878B-0D64F2F8A989Q37121686-83D49CC1-AF8C-4182-BDB6-954F8E2A494DQ37490046-BD376A34-B2CD-4659-B7EA-50AA098E7B2BQ38075561-4365E889-B0CD-42C4-9730-B1E34F3AE8D9Q38199738-23D680CB-4BCB-499B-9D9A-96BDD36D824AQ38243175-1F5674C6-66F2-4F05-B36B-DF001A1DE691Q38289596-5F29349B-8999-4048-BED9-C17028516F25Q38525578-70EFBDFE-1B44-4852-90D0-7FD1C1194189Q38895172-1615DF3F-709D-4425-A825-9C60DBB01C35Q40582133-0FF9E68A-A2C0-458A-A437-38B2CFFF634AQ41068390-E2E889D3-D31D-4339-BE5C-83FB1F7A107BQ41667877-7B035A08-3B9E-40D0-A2AD-FCD02A727081Q42771564-2E8FB3BF-B6E4-4F2D-ADD5-1473FE92C05EQ43833709-F4B67BCB-CC04-469D-96E6-2E65893EE730Q46377291-8AD0EDAC-6119-4E62-94C5-855E126F8436Q48263723-4704B2CF-64DE-423F-ADE1-CC9392E424C0Q57817595-2BFAC90E-9890-42DC-A889-FF185A2D38A0
P2860
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
PACSIN2 polymorphism influence ...... ated gastrointestinal toxicity
@ast
PACSIN2 polymorphism influence ...... ated gastrointestinal toxicity
@en
type
label
PACSIN2 polymorphism influence ...... ated gastrointestinal toxicity
@ast
PACSIN2 polymorphism influence ...... ated gastrointestinal toxicity
@en
prefLabel
PACSIN2 polymorphism influence ...... ated gastrointestinal toxicity
@ast
PACSIN2 polymorphism influence ...... ated gastrointestinal toxicity
@en
P2093
P2860
P50
P356
P1476
PACSIN2 polymorphism influence ...... ated gastrointestinal toxicity
@en
P2093
Barthelemy Diouf
Cheng Cheng
Deqing Pei
Joseph Robert McCorkle
Kristine R Crews
Marco Rabusin
Margherita Londero
Maria Grazia Valsecchi
Mary V Relling
Raffaella Franca
P2860
P304
P356
10.1093/HMG/DDS302
P577
2012-07-30T00:00:00Z